Atlas FDA

ACCURUN 140 RUBELLA IGG POSITIVE CONTROL

FDA 510(k) clearance K972986 · decided 1997-10-08

Clearance details

K-number
K972986
Device name
ACCURUN 140 RUBELLA IGG POSITIVE CONTROL
Applicant
Boston Biomedica, Inc.
Decision
Substantially Equivalent
Date received
1997-08-11
Decision date
1997-10-08
Days to decision
58 days
Clearance type
Traditional
Product code
MJX
Device class
1
Regulation number
862.1660
Medical specialty
Clinical Chemistry
Advisory committee
Clinical Chemistry
Location
West Bridgewater, MA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Boston Biomedica

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
AUDIT MICROCV PROCALCITONIN LINEARITY (K101434)Aalto Scientific, Ltd.2010-07-22
VITROS IMMUNODIAGNOSTIC PRODUCTS HBSAG CONTROLS (K030067)Ortho-Clinical Diagnostics2003-01-17
SYSCOS IDC - G, IDC, BSC, IDC - G (K974262)Scantibodies Laboratory, Inc.1997-12-24
TECH SIMPLE SYPHILIS POSITIVE SERUM CONTROL MONITOR ONTRAK SYPHILIS POSITIVE SERUM CONTROL (K970100)Simplicity Diagnostics, Inc.1997-03-10
OPUS(R) SEROLOGY CONTROLS, MODIFICATION (K934137)Pb Diagnostic Systems, Inc.1994-03-07
OPUS SEROLOGY CONTROLS (K925703)Pb Diagnostics, Inc.1993-04-08

Recalls involving this device

No recalls on record reference this clearance.